Cellebrite DI (CLBT) Other financing activities (2020 - 2026)

Cellebrite DI has reported Other financing activities for 7 years, with the latest figure at $2.1 million in Q2 2026.

• On a quarterly basis, Other financing activities fell 83.18% year-over-year to $2.1 million in Q2 2026; TTM through Jun 2026 was $9.2 million, a 63.79% decrease from a year earlier, with the FY2025 full-year figure at $20.1 million, up 16.4% from the prior year.
• Other financing activities was $2.1 million for Q2 2026 at Cellebrite DI, roughly flat from $2.1 million in the prior quarter.
• The five-year high for Other financing activities was $12.6 million in Q2 2025, with the low at $1.0 million in Q4 2025.
• Average Other financing activities over 5 years is $4.1 million, with a median of $3.7 million recorded in 2022.
• The sharpest annual moves came in 2022 and 2026: Other financing activities jumped 463.71% in 2022, then tumbled 83.18% in 2026.
• Over 5 years, Other financing activities stood at $1.3 million in 2022, then soared by 188.39% to $3.8 million in 2023, then soared by 50.41% to $5.8 million in 2024, then tumbled by 82.24% to $1.0 million in 2025, then surged by 107.73% to $2.1 million in 2026.
• The last three Other financing activities figures came in at $2.1 million (Q2 2026), $2.1 million (Q1 2026), and $1.0 million (Q4 2025), per Business Quant data.